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SUMMARY
Background and Purpose 
Epilepsy is highly prevalent in developing African countries with significant morbidity, social stigmatization, 
poor  quality of  life  and preventable mortality.  There are  scanty reports  on the contributions  of  seizure 
variables like seizure types, frequency of seizures, duration of epilepsy, age at onset and anti-epileptic drugs 
to cognitive disturbances in Nigerian Africans. This study assessed the effects of seizure variables on the 
cognitive performances of patients with epilepsy.
Methods 
The  cognitive  functions  of  41 patients  with  epilepsy and 41 controls  were  assessed with  a  computer-
assisted cognitive test battery, Iron Psychology (acronym - FePsy) using the simple and complex reaction 
time tasks for mental speed, recognition memory test (RMT) for memory and continuous performance test 
for attention.
Results 
The cognitive performances of the patients using complex reaction time and the recognition memory tasks 
were  worse  than  those  of  the  controls  (p<0.05).  The  duration  of  treatment  with  anti-epileptic  drugs 
negatively affected all cognitive domains assessed. The seizure frequency, duration of epilepsy and the use 
of phenytoin were associated with psychomotor retardation and impaired memory.
Conclusions 
The  seizure  variables  negatively  affected  cognitive  performances  of  Nigerian  patients  with  epilepsy. 
Cognitive assessment is recommended as part of regular evaluation of patients with epilepsy.
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INTRODUCTION
Epilepsy is the second most common disorder of the central nervous system, affecting 1% of the human 
population (3). It is particularly highly prevalent in developing African countries (24,28). The concern over the 
quality of life of patients with epilepsy (PWE) has attracted many attempts at elucidating the impact of seizure 
variables like seizure types, frequency of seizures, duration of  epilepsy, and effect of  anti-epileptic drugs 
(AEDs)  on the  cognitive  functioning  of  these  patients.  Several  reports  have  confirmed  the  presence  of 
cognitive  disturbances  in  PWE and  the  consequences  on  their  day-to-day activities  (1,  9,  20,  29,  30). 
Cognitive deterioration observed in epilepsy may arise ab initio as a result of the epilepsy as the same brain 
dysfunction  that  causes  the  seizures  can  also  lead  to  learning  disabilities,  memory  impairment  and 
psychomotor retardation (1,24,28) or it may be secondary to anti-epileptic medications which can exacerbate 
these cognitive disturbances (9,29). 
Several reports have shown that cognitive deterioration is worse among patients with generalized seizures 
than among those with partial seizures (12,15). This explains the contribution of cognitive impairment to poor 
quality of life among these patients with generalized epilepsies. The longer the duration of epilepsy the higher 
the likelihood of cognitive deterioration (6, 14) though it has been reported that duration of epilepsy has no 
effect on cognition (13). Though cognitive disturbances have been noted in newly diagnosed PWE (20, 26), 
but  more  importantly is  the contribution of  the anti-epileptic drugs (AEDs).  Anti-epileptic drugs  can also 
contribute to cognitive impairments especially those drugs with significant sedative effects. Phenobarbitone, 
diazepam, phenytoin,  sodium valproate and carbamazepine have all  been shown to affect  the cognitive 
abilities of PWE but in differing degrees (9, 29, 31). The effect on cognition is worse with phenobarbitone and 
diazepam (25, 29).
Anti-epileptic drugs (AEDs) may cause impairments in cognitive functions such as attention, memory and 
psychomotor speed. There is evidence that drug-induced cognitive impairment has great impact on critical 
daily life function of patients with epilepsy (1,9). The cognitive effects of AEDs are of special concern because 
they are iatrogenically induced (1).
Comparative studies of AEDs in developed countries have shown that while carbamazepine had minimal side 
effects, phenytoin and phenobarbitone have less favorable cognitive side effects with impairments of mental 
speed, memory and attention (29,  30,31).  These latter  two drugs are however the most  widely used in 
developing countries, because of good efficacy, broad spectrum of activity and low cost (10,19).
This study was designed to assess the effects of seizure variables, namely; duration of epilepsy, frequency of 
seizures, seizure types, type of anti-epileptic medication, duration of AED use and age at onset of seizures on 
the cognitive performances of our patients with epilepsy. A computerized cognitive assessment test battery, 
the FePsy(16) which has been validated earlier among Nigerians (21) was used to assess the memory, 
attention, concentration and psychomotor speed of the patients.
PATIENTS AND METHODS
The cohort comprised of forty-one patients with epilepsy (PWE) and forty-one sex-, age-, level of education- 
and socio-economic-matched controls. The study participants were adult patients attending the Neurology 
clinic of Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, a tertiary health facility situated in 
metropolitan Nigeria. Informed consent was obtained from each subject before commencement of the study. 
The ethical committee of the hospital gave approval for the study. The inclusion criteria included patients 
aged between 16 and 55years with history of epilepsy as defined by the characteristic eye witness of at least 
two separate unprovoked non-febrile seizures. Patient must have also completed at least primary school 
education (some of the test items require subjects to be literate) and must be on phenytoin or carbamazepine 
therapy only to avoid the confounding effects of polytherapy. These two drugs are the most commonly used 
anti-epileptic  drugs  in  our  center.  The  exclusion  criteria  included  use  of  antiepileptic  drugs  other  than 
phenytoin or  carbamazepine,  seizures secondary to other  causes  (such  as  fever,  infection,  head injury, 
cerebrovascular disease), patients with visual and/or hearing impairment, musculoskeletal abnormalities and 
seizures  occurring  24  hours  preceding  cognitive  functions  assessment.  The  controls  were  age,  sex, 
education and social status matched with PWE and they had no family history of seizures. A questionnaire 
was developed and applied to all subjects. History was taken from patients and eye witnesses. Emphasis was 
placed on demographic data (age, sex, level of education) and details of seizure variables which include 
duration of seizures, seizure types, type of AED administered and duration of drug therapy, age at onset of 
epilepsy and frequency of seizures. The history of birth, perinatal injury, fever, head injury and drug abuse 
was sought. Detailed general physical examination was carried out on each subject and the seizure types 
were classified according to the International League against Epilepsy (ILAE 1981) criteria (21). The cognitive 
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performances of  the PWE and controls were assessed with the computerized cognitive assessment test 
battery, the FePsy (19). Electroencephalographic (EEG) studies were done in all the patients.
The  differences  in  sex,  age  and level  of  education of  the PWE and controls  were tested for  statistical 
significance with the chi-square test. The difference in the cognitive performances of the PWE and controls 
was analyzed using Student t test. The impact of seizure variables on cognitive performances in PWE was 
analyzed using 2-way Analysis of Variance (ANOVA). The level of significance was taken as p <0.05.
RESULTS
The study participants comprised 41 PWE and 41 controls with mean ages of  28.32(± 9.22) years and 
25.95(± 7.72) years respectively. There were 20 males and 21 females in the PWE group and 26 males and 
15 females in the control group. Other demographic details of the study participants are as outlined in table 1.
Majority  of  the  PWE  had  generalized  epilepsies  (73.2%)  with  approximately  half  of  this  group  having 
secondarily generalized seizures. Complex partial seizures were found to be commoner than simple partial 
seizures. Most of the patients (65.9%) presented in the second and third decades of life. More than half 
(51.2%) of the patients who participated in the study had had seizures for more than five years. Sixteen of the 
patients (39%) had frequent seizures i.e. seizures in excess of more than or equal to one fit in 3-6 months. 
Carbamazepine was used in most of the patients to achieve seizure control (66.7%).
The cognitive performances of the patients with epilepsy (PWE) and the controls are presented in table 3. 
The PWE had prolonged response time in both auditory and visual reaction tasks when compared to the 
controls but this difference did not reach statistical significance (p>0.05). There was however a significant 
difference in the psychomotor speed of the PWE and that of the controls using the complex reaction task 
(binary choice reaction task). In addition, the concentration ability of the PWE was significantly impaired as 
shown by their lower percentage of correct responses (p<0.01). The PWE were significantly impaired in their 
attention span (p=0.005) but not in their recall abilities (p= 0.07).
The effects of the seizure variables on the various cognitive tasks performance are presented on table 4. The 
frequency of  seizures  and  the  type  of  epilepsy did  not  affect  the  cognitive  performances  of  the  PWE 
significantly with the exception of their concentration abilities which was negatively impacted by the seizure 
frequency using the binary choice reaction task (p=0.035).
The duration of epilepsy significantly affected the concentration abilities and the verbal memory performance 
of the PWE negatively (p<0.05) but had no statistically significant effect on other cognitive tasks. The age at 
onset of epilepsy did not show any appreciable significant effect on their cognitive functioning.
The type of medication i.e. AED administered to the patient had no effect on the cognitive performance with 
the  exception  of  the auditory reaction  time which  was significantly prolonged  using  the  dominant  hand 
(p=0.014) among PWE on phenytoin. The duration of therapy however significantly affected their reaction 
time (both auditory and visual), concentration and attention, and their information recall abilities (p<0.05).
DISCUSSION
Cognitive deterioration in epilepsy has been associated with poor quality of life, marital disharmony and family 
breakup, inability to secure employment, retrenchment from work, academic disruption and social stigma (5). 
Most  patients  with  epilepsy report  memory impairment  during clinic  visits  as  this  obviously disrupt  their 
academic performance (20,27). Cognitive dysfunctions which have been associated with epilepsy include 
memory impairment, psychomotor retardation, inattention and lack of concentration, reduced motor speed 
and in patients with significant brain damage impaired visual scanning task (1,9,12,20,26). In this study the 
lack of significant difference in psychomotor and recognition memory performances of the PWE and controls 
using  the  auditory  and  visual  simple  reaction  time  tasks  is  inconsistent  with  previously  documented 
observations in the literature. This may be as a result of the type of cognitive tests used or the small sample 
size, though we opined that it is likely due to the latter. A previous publication by Ogunrin et al (20) that 
studied a larger sample size and used similar cognitive tests showed significant difference between PWE and 
controls.
Despite the fact that the etiology of the epilepsy may cause cognitive disruption by itself, the contributory roles 
of various seizure variables need evaluation. This study showed inconsistent pattern when effects of seizure 
frequency and  epilepsy type  on  cognitive  performance  were  assessed.  The  seizure  frequency affected 
concentration ability but had no effect on mental speed, an observation that is  not consistent with most 
reports in the literature. The lack of effect was noted when the simple reaction tasks were used to assess the 
(psychomotor)  mental  speed of  the  patients.  Furthermore,  the  pattern  of  performance  showed a  faster 
response with the non-dominant hands for the auditory (simple) reaction task, an observation which has been 
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reported earlier and is different with what was observed by researchers in the western countries (20).
The negative impact on mental speed was however noted with complex (binary) reaction task. This suggests 
that more complex cognitive tasks may be more demanding and difficult to cope with in epilepsy. The same 
pattern was observed for duration of epilepsy and type of medication used.
It has been established that the higher the frequency of seizures the more severe the cognitive dysfunctions 
thus underscoring the importance of  effective and optimal seizure control  with appropriate AEDs (2,27). 
Evidences from the literature clearly show that the more frequent the attacks  of  seizures,  the more the 
likelihood of impaired cognition for both idiopathic and symptomatic epilepsies (1,30). It is likely that recurrent 
seizures with loss of consciousness directly results in cognitive disturbances by interfering with learning, and 
indirectly by causing  cerebral  damage,  especially in  patients  with  chronic  epilepsy (1,7,12,14).  A  direct 
relationship between the number of seizure attacks and cell loss in the hippocampus, an essential structure 
in some memory processes, has been reported (17). Twin studies have also shown that the twin with more 
frequent seizures performed worse on tests of cognitive functions (7). The degree of seizure control thus 
appears to be important as good control has been associated with better performance (18).
The age at onset of seizures and the seizure type appeared to have no significant effects on the cognitive 
abilities of the PWE. This is at variance with earlier observations (6, 14, 15,18). Early onset of seizures is 
recognized to have deleterious effect on cognition (27). Since childhood is an important period during which 
one starts learning, then onset of epilepsy during childhood interferes greatly with the acquisition of learning 
abilities. Many authors have noted that the onset of seizures in early childhood is associated with a higher risk 
of cognitive impairment than when seizures started in late childhood or the teenage years.
Attempts  to  associate  seizure  types  with  cognitive  function  have  not  yielded  entirely consistent  results. 
Generalised  absence  seizures  have  been  reported  to  be  less  damaging  than  generalised  tonic-  clonic 
seizures,  and patients with partial  seizures performed better  on tests of  cognitive  tasks  than those with 
generalised seizures (6,27).
The  cognitive  performance  was  however  worse  in  PWE  on  phenytoin  when  compared  with  those  on 
carbamazepine. This pattern has been consistently noted by other authors (8,23,29,31).  The duration of 
therapy affected all the cognitive tasks assessed portraying the contributory role of prolonged administration 
of AED on cognitive functioning of PWE. It is important to emphasize that the inconsistencies observed with 
this study may not be unrelated to the small sample size. Most of the earlier studies among Nigerian Africans 
assessed larger sample sizes of PWE. Apart from the limitation of small sample size, the other limitation of 
this study is our inability to assess the serum levels of the AEDs (carbamazepine and phenytoin) in these 
patients.
 
Table 1: Demographic details of subjects
chi-square value: P-level of significance; P < 0.05-significant
a: patients with epilepsy
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Table 2: Seizure variables in PWE
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Table 3: Cognitive performances of the PWE and the controls
a auditory reaction time measured in milliseconds using the dominant and non-dominant hands 
b visual reaction time measured in milliseconds using the dominant and non-dominant hands 
c binary choice reaction time; *time taken to complete the binary choice reaction time measured in 
milliseconds 
**percentage of correct responses 
d perceptual sensitivity - a measure of attention on continuous performance test 
e response bias - a measure of bias in consistency of performance 
f recognition memory test expressed as percentage of correct responses
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Table 4: Impact of Seizure Variables on Cognitive Functioning in PWE Using Fepsy Scores
a auditory reaction time with dominant hand (Dom) and non-dominant hand (Non-Dom) measured in 
milliseconds) 
b visual reaction time with dominant hand (Dom) and non-dominant hand (Non-Dom) measured in 
milliseconds) 
c binary (complex) choice reaction time task 
d perceptual sensitivity (measure of attention); β - measure of response bias 
e recognition memory test
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